134. In regulation 167 (insertion of regulation 205A (further obligations in respect of pharmacovigilance activities)), in the inserted regulation 205A—U.K.
(a)in paragraph (1), after “Schedule 12A” insert “ applies in relation to medicinal products for sale or supply under a UKMA(GB) or THR(GB) and ”;
(b)in paragraph (2)—
(i)for “The Ministers” substitute “ The Secretary of State ”;
(ii)after “by regulations” insert “ in respect of Great Britain ”.
Commencement Information
I1Sch. 2 para. 134 in force at 31.12.2020 immediately before IP completion day, see reg. 1